annual EBIT:
-$150.92M-$50.09M(-49.68%)Summary
- As of today (May 29, 2025), VKTX annual earnings before interest & taxes is -$150.92 million, with the most recent change of -$50.09 million (-49.68%) on December 31, 2024.
- During the last 3 years, VKTX annual EBIT has fallen by -$95.24 million (-171.04%).
- VKTX annual EBIT is now -123910.68% below its all-time high of -$121.70 thousand, reached on December 31, 2013.
Performance
VKTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$55.47M-$9.23M(-19.96%)Summary
- As of today (May 29, 2025), VKTX quarterly earnings before interest & taxes is -$55.47 million, with the most recent change of -$9.23 million (-19.96%) on March 31, 2025.
- Over the past year, VKTX quarterly EBIT has dropped by -$21.40 million (-62.79%).
- VKTX quarterly EBIT is now -3330.20% below its all-time high of $1.72 million, reached on December 31, 2014.
Performance
VKTX quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$172.32M-$21.40M(-14.18%)Summary
- As of today (May 29, 2025), VKTX TTM earnings before interest & taxes is -$172.32 million, with the most recent change of -$21.40 million (-14.18%) on March 31, 2025.
- Over the past year, VKTX TTM EBIT has dropped by -$57.95 million (-50.68%).
- VKTX TTM EBIT is now -157123.54% below its all-time high of -$109.60 thousand, reached on December 31, 2012.
Performance
VKTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
VKTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -49.7% | -62.8% | -50.7% |
| 3 y3 years | -171.0% | -241.4% | -198.7% |
| 5 y5 years | -361.7% | -406.7% | -367.9% |
VKTX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -171.0% | at low | -242.5% | at low | -198.7% | at low |
| 5 y | 5-year | -361.7% | at low | -480.7% | at low | -368.1% | at low |
| alltime | all time | <-9999.0% | at low | -3330.2% | at low | <-9999.0% | at low |
VKTX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$55.47M(+20.0%) | -$172.32M(+14.2%) |
| Dec 2024 | -$150.92M(+49.7%) | -$46.24M(+26.5%) | -$150.92M(+12.7%) |
| Sep 2024 | - | -$36.56M(+7.3%) | -$133.97M(+7.5%) |
| Jun 2024 | - | -$34.05M(-0.1%) | -$124.68M(+9.0%) |
| Mar 2024 | - | -$34.07M(+16.3%) | -$114.36M(+13.4%) |
| Dec 2023 | -$100.83M(+43.3%) | -$29.29M(+7.4%) | -$100.83M(+9.8%) |
| Sep 2023 | - | -$27.27M(+14.8%) | -$91.83M(+13.7%) |
| Jun 2023 | - | -$23.74M(+15.6%) | -$80.76M(+8.2%) |
| Mar 2023 | - | -$20.54M(+1.3%) | -$74.65M(+6.1%) |
| Dec 2022 | -$70.36M(+26.4%) | -$20.28M(+25.2%) | -$70.36M(+12.4%) |
| Sep 2022 | - | -$16.20M(-8.1%) | -$62.58M(+4.7%) |
| Jun 2022 | - | -$17.63M(+8.5%) | -$59.79M(+3.6%) |
| Mar 2022 | - | -$16.25M(+29.9%) | -$57.70M(+3.6%) |
| Dec 2021 | -$55.68M(+30.5%) | -$12.51M(-6.7%) | -$55.68M(+2.3%) |
| Sep 2021 | - | -$13.40M(-13.8%) | -$54.44M(+7.0%) |
| Jun 2021 | - | -$15.54M(+9.2%) | -$50.88M(+13.3%) |
| Mar 2021 | - | -$14.23M(+26.3%) | -$44.89M(+7.9%) |
| Dec 2020 | -$42.66M(+30.5%) | -$11.27M(+14.5%) | -$41.61M(+6.1%) |
| Sep 2020 | - | -$9.84M(+3.0%) | -$39.22M(+6.5%) |
| Jun 2020 | - | -$9.55M(-12.8%) | -$36.81M(-0.0%) |
| Mar 2020 | - | -$10.95M(+23.4%) | -$36.83M(+12.7%) |
| Dec 2019 | -$32.69M | -$8.87M(+19.3%) | -$32.69M(+12.5%) |
| Sep 2019 | - | -$7.44M(-22.3%) | -$29.05M(+3.0%) |
| Jun 2019 | - | -$9.57M(+40.6%) | -$28.21M(+12.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$6.81M(+29.9%) | -$25.17M(+16.2%) |
| Dec 2018 | -$21.66M(+12.3%) | -$5.24M(-20.6%) | -$21.66M(+7.0%) |
| Sep 2018 | - | -$6.60M(+1.1%) | -$20.25M(+3.9%) |
| Jun 2018 | - | -$6.53M(+98.2%) | -$19.49M(+9.5%) |
| Mar 2018 | - | -$3.29M(-14.0%) | -$17.80M(-7.8%) |
| Dec 2017 | -$19.30M(+49.3%) | -$3.83M(-34.5%) | -$19.29M(+3.3%) |
| Sep 2017 | - | -$5.84M(+20.9%) | -$18.68M(+15.2%) |
| Jun 2017 | - | -$4.83M(+0.9%) | -$16.21M(+11.5%) |
| Mar 2017 | - | -$4.79M(+49.2%) | -$14.54M(+12.5%) |
| Dec 2016 | -$12.92M(-42.4%) | -$3.21M(-4.9%) | -$12.92M(-11.2%) |
| Sep 2016 | - | -$3.37M(+6.6%) | -$14.55M(-7.1%) |
| Jun 2016 | - | -$3.17M(-0.2%) | -$15.66M(-22.0%) |
| Mar 2016 | - | -$3.17M(-34.4%) | -$20.09M(-10.4%) |
| Dec 2015 | -$22.42M(+5.5%) | -$4.84M(+7.8%) | -$22.42M(+41.3%) |
| Sep 2015 | - | -$4.49M(-40.9%) | -$15.87M(+38.9%) |
| Jun 2015 | - | -$7.59M(+38.0%) | -$11.42M(-57.0%) |
| Mar 2015 | - | -$5.50M(-420.5%) | -$26.54M(+24.9%) |
| Dec 2014 | -$21.26M(>+9900.0%) | $1.72M(-4382.3%) | -$21.26M(-7.5%) |
| Sep 2014 | - | -$40.10K(-99.8%) | -$22.97M(+0.2%) |
| Jun 2014 | - | -$22.71M(>+9900.0%) | -$22.93M(+9576.2%) |
| Mar 2014 | - | -$220.00K(+1194.1%) | -$237.00K(+82.6%) |
| Dec 2013 | -$121.70K | - | - |
| Jun 2013 | - | -$17.00K(+431.3%) | -$129.80K(+15.1%) |
| Mar 2013 | - | -$3200.00(-97.1%) | -$112.80K(+2.9%) |
| Dec 2012 | - | -$109.60K | -$109.60K |
FAQ
- What is Viking Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Viking Therapeutics?
- What is Viking Therapeutics annual EBIT year-on-year change?
- What is Viking Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Viking Therapeutics?
- What is Viking Therapeutics quarterly EBIT year-on-year change?
- What is Viking Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Viking Therapeutics?
- What is Viking Therapeutics TTM EBIT year-on-year change?
What is Viking Therapeutics annual earnings before interest & taxes?
The current annual EBIT of VKTX is -$150.92M
What is the all time high annual EBIT for Viking Therapeutics?
Viking Therapeutics all-time high annual earnings before interest & taxes is -$121.70K
What is Viking Therapeutics annual EBIT year-on-year change?
Over the past year, VKTX annual earnings before interest & taxes has changed by -$50.09M (-49.68%)
What is Viking Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of VKTX is -$55.47M
What is the all time high quarterly EBIT for Viking Therapeutics?
Viking Therapeutics all-time high quarterly earnings before interest & taxes is $1.72M
What is Viking Therapeutics quarterly EBIT year-on-year change?
Over the past year, VKTX quarterly earnings before interest & taxes has changed by -$21.40M (-62.79%)
What is Viking Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of VKTX is -$172.32M
What is the all time high TTM EBIT for Viking Therapeutics?
Viking Therapeutics all-time high TTM earnings before interest & taxes is -$109.60K
What is Viking Therapeutics TTM EBIT year-on-year change?
Over the past year, VKTX TTM earnings before interest & taxes has changed by -$57.95M (-50.68%)